Susan Elizabeth Arnold - Jul 12, 2021 Form 4/A - Amendment Insider Report for PhaseBio Pharmaceuticals Inc (PHASQ)

Role
VP, Preclinical and Chem
Signature
/s/ John P. Sharp, Attorney-in-fact
Stock symbol
PHASQ
Transactions as of
Jul 12, 2021
Transactions value $
$7,863
Form type
4/A - Amendment
Date filed
9/3/2021, 04:43 PM
Date Of Original Report
Jul 14, 2021
Previous filing
May 24, 2021
Next filing
Nov 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Options Exercise $7.86K +4.52K +19.44% $1.74* 27.8K Jul 12, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHASQ Employee Stock Option (right to buy) Options Exercise $0 -4.52K -100% $0.00* 0 Jul 12, 2021 Common Stock 4.52K $1.74 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amended to correct the transaction code for common stock acquired through stock options exercised in a transaction on July 12, 2021.
F2 Amended to add a transaction for the exercise of stock options on July 12, 2021.
F3 All shares underlying this option have vested.